Osaic Holdings’s Antares Pharma, Inc. ATRS Stock Holding History

Osaic Holdings’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-110,111	Closed	-$553K	–	7839
2022 Q1	$553K	Buy	110,111 +408	+0.4%	+$1.48K	﹤0.01%	3134
2021 Q4	$392K	Sell	109,703 -12,880	-11%	-$45K	﹤0.01%	3307
2021 Q3	$447K	Buy	122,583 +1,465	+1%	+$5.92K	﹤0.01%	3149
2021 Q2	$528K	Sell	121,118 -2,527	-2%	-$10.3K	﹤0.01%	2977
2021 Q1	$508K	Buy	123,645 +4,241	+4%	+$18.4K	﹤0.01%	2847
2020 Q4	$477K	Sell	119,404 -3,000	-2%	-$9.71K	﹤0.01%	2686
2020 Q3	$331K	Sell	122,404 -750	-0.6%	-$2.08K	﹤0.01%	2807
2020 Q2	$339K	Buy	123,154 +6,599	+6%	+$18.4K	﹤0.01%	2674
2020 Q1	$274K	Buy	+116,555	New	+$396K	﹤0.01%	2605

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings's ATRS Position: Q2 2022 in Review

Osaic Holdings sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 110,111 shares — an estimated $553K sold.

Osaic Holdings first reported a position in ATRS in Q1 2020 and held it in 9 quarters. The position peaked at $553K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Osaic Holdings reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Osaic Holdings sold 110,111 Antares Pharma, Inc. shares in Q2 2022, an estimated $553K.
Osaic Holdings first reported a position in Antares Pharma, Inc. in Q1 2020 and held it in 9 quarters.
Osaic Holdings's Antares Pharma, Inc. position peaked at $553K in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Osaic Holdings's 13F filing for Q2 2022, filed 10 Aug 2022.